130 related articles for article (PubMed ID: 8652861)
1. bcl-2, Epstein-Barr virus-latent membrane protein, EBNA-1, and EBNA-2 staining in posttransplantation lymphoproliferative disorders.
Chetty R; Biddolph S; Gatter K
Blood; 1996 Jun; 87(12):5395. PubMed ID: 8652861
[No Abstract] [Full Text] [Related]
2. Expression of Epstein-Barr virus-encoded latent membrane protein 1 in nonendemic Burkitt's lymphomas.
Carbone A; Gloghini A; Zagonel V; Tirelli U
Blood; 1996 Feb; 87(3):1202-4. PubMed ID: 8562951
[No Abstract] [Full Text] [Related]
3. BCL-2 but not its Epstein-Barr virus-encoded homologue, BHRF1, is commonly expressed in posttransplantation lymphoproliferative disorders.
Murray PG; Swinnen LJ; Constandinou CM; Pyle JM; Carr TJ; Hardwick JM; Ambinder RF
Blood; 1996 Jan; 87(2):706-11. PubMed ID: 8555494
[TBL] [Abstract][Full Text] [Related]
4. Heterogeneous expression of Epstein-Barr virus latent proteins in endemic Burkitt's lymphoma.
Niedobitek G; Agathanggelou A; Rowe M; Jones EL; Jones DB; Turyaguma P; Oryema J; Wright DH; Young LS
Blood; 1995 Jul; 86(2):659-65. PubMed ID: 7605996
[TBL] [Abstract][Full Text] [Related]
5. Lack of the expression of EBNA-2 and LMP-1 in T-cell neoplasms possessing Epstein-Barr virus.
Suzushima H; Asou N; Fujimoto T; Nishimura S; Okubo T; Yamasaki H; Osato M; Matsuoka M; Tsukamoto A; Takai K
Blood; 1995 Jan; 85(2):480-6. PubMed ID: 7812002
[TBL] [Abstract][Full Text] [Related]
6. High expression of latent membrane protein 1 of Epstein-Barr virus and BCL-2 oncoprotein in acquired immunodeficiency syndrome-related primary brain lymphomas.
Camilleri-Broët S; Davi F; Feuillard J; Bourgeois C; Seilhean D; Hauw JJ; Raphaël M
Blood; 1995 Jul; 86(2):432-5. PubMed ID: 7605982
[TBL] [Abstract][Full Text] [Related]
7. The expression of Epstein-Barr virus latent proteins is related to the pathological features of post-transplant lymphoproliferative disorders.
Delecluse HJ; Kremmer E; Rouault JP; Cour C; Bornkamm G; Berger F
Am J Pathol; 1995 May; 146(5):1113-20. PubMed ID: 7747805
[TBL] [Abstract][Full Text] [Related]
8. Epstein-Barr virus latent gene expression in primary effusion lymphomas containing Kaposi's sarcoma-associated herpesvirus/human herpesvirus-8.
Horenstein MG; Nador RG; Chadburn A; Hyjek EM; Inghirami G; Knowles DM; Cesarman E
Blood; 1997 Aug; 90(3):1186-91. PubMed ID: 9242551
[TBL] [Abstract][Full Text] [Related]
9. EBV-NK cells interactions and lymphoproliferative disorders.
Kanegane H; Yachie A; Miyawaki T; Tosato G
Leuk Lymphoma; 1998 May; 29(5-6):491-8. PubMed ID: 9643562
[TBL] [Abstract][Full Text] [Related]
10. The role of Epstein-Barr virus in the pathogenesis of Hodgkin's disease.
Khan G; Coates PJ
J Pathol; 1994 Nov; 174(3):141-9. PubMed ID: 7823246
[No Abstract] [Full Text] [Related]
11. Pharmacologic activation of expression of immunodominant viral antigens: a new strategy for the treatment of Epstein-Barr-virus-associated malignancies.
Robertson KD; Barletta J; Samid D; Ambinder RF
Curr Top Microbiol Immunol; 1995; 194():145-54. PubMed ID: 7534666
[No Abstract] [Full Text] [Related]
12. Post-transplantation lymphoproliferative disorders in Mexico: an aggressive clonal disease associated with Epstein-Barr virus type A.
Quintanilla-Martínez L; Lome-Maldonado C; Schwarzmann F; Gredler E; Reyes E; Angeles-Angeles A; Fend F
Mod Pathol; 1998 Feb; 11(2):200-8. PubMed ID: 9504692
[TBL] [Abstract][Full Text] [Related]
13. EBV gene expression, EBNA antibody responses and EBV+ peripheral blood lymphocytes in post-transplant lymphoproliferative disease.
McKnight JL; Cen H; Riddler SA; Breinig MC; Williams PA; Ho M; Joseph PS
Leuk Lymphoma; 1994 Sep; 15(1-2):9-16. PubMed ID: 7858507
[TBL] [Abstract][Full Text] [Related]
14. Human herpesvirus-6 (HHV-6) in Hodgkin's disease: cellular expression of viral antigens as compared to oncogenes met and fes, tumor suppressor gene product p53, and interleukins 2 and 6.
Krueger GR; Guenther A; Knuefermann R; Kluppelberg U; Luka J; Pearson GR; Ablashi DV; Juecker M; Tesch H
In Vivo; 1994; 8(4):501-16. PubMed ID: 7893977
[TBL] [Abstract][Full Text] [Related]
15. Expression of Epstein-Barr virus-gene products in Burkitt's lymphoma in Northeast Brazil.
Araujo I; Foss HD; Bittencourt A; Hummel M; Demel G; Mendonca N; Herbst H; Stein H
Blood; 1996 Jun; 87(12):5279-86. PubMed ID: 8652843
[TBL] [Abstract][Full Text] [Related]
16. Expression of Epstein-Barr virus-encoded growth-transformation-associated proteins in lymphoproliferations of bone-marrow transplant recipients.
Gratama JW; Zutter MM; Minarovits J; Oosterveer MA; Thomas ED; Klein G; Ernberg I
Int J Cancer; 1991 Jan; 47(2):188-92. PubMed ID: 1846349
[TBL] [Abstract][Full Text] [Related]
17. Expression of bcl-2 in Burkitt's lymphoma cell lines: induction by latent Epstein-Barr virus genes.
Finke J; Fritzen R; Ternes P; Trivedi P; Bross KJ; Lange W; Mertelsmann R; Dölken G
Blood; 1992 Jul; 80(2):459-69. PubMed ID: 1378321
[TBL] [Abstract][Full Text] [Related]
18. Full presence of Epstein-Bar virus (EBV)-encoded latent proteins in tissues from a patient with severe chronic active EBV infection syndrome.
Okano M; Davis JR; Thiele GM
Acta Haematol; 1997; 97(4):242-3. PubMed ID: 9158671
[No Abstract] [Full Text] [Related]
19. Posttransplantation lymphoproliferative disorders frequently contain type A and not type B Epstein-Barr virus.
Frank D; Cesarman E; Liu YF; Michler RE; Knowles DM
Blood; 1995 Mar; 85(5):1396-403. PubMed ID: 7858270
[TBL] [Abstract][Full Text] [Related]
20. [Epstein-Barr virus infection and the expression of bcl-2 proto-oncogene in Hodgkin's disease].
Liu C; Liao S; Gao Z
Zhonghua Bing Li Xue Za Zhi; 1997 Jun; 26(3):155-7. PubMed ID: 10072857
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
